Genome Technologies Coordinating Center

基因组技术协调中心

基本信息

  • 批准号:
    10408042
  • 负责人:
  • 金额:
    $ 149.81万
  • 依托单位:
  • 依托单位国家:
    美国
  • 项目类别:
  • 财政年份:
    2021
  • 资助国家:
    美国
  • 起止时间:
    2021-05-20 至 2025-02-28
  • 项目状态:
    未结题

项目摘要

PROJECT SUMMARY The Genome Technology portfolio at NHGRI encompasses a substantial diversity of scientific approaches and objectives, from instrumentation development to high-throughput application of technologies to characterizing the genomic basis for phenotypic traits. These research efforts have produced significant insight into biology and disease, and yet there are many opportunities to accelerate innovation, development, and early dissemination of genomic technologies. The goal of the Genome Technology Coordinating Center (GTCC) is to maximize these opportunities by liaising grantees and NHGRI Program Staff, managing research funds, and developing educational resources to support and tout the excellence of the Genome Technology program. We propose the following aims to meet these goals: 1) Facilitate collaborations across the Genome Technology Program and promote standards that aid in achieving Program goals. We will host and support Annual meetings for the Genome Technology and CEGS programs. We will also develop Working Groups among grantees to promote collaboration-building and the development of metrics and standards for genomic technologies. We will use these Working Groups to identify gaps in the field that will provide the foundation for solicitation of Opportunity Funds. 2) Establish and manage an Opportunity Funds program to support initial development of promising new technologies and ideas. These Opportunity Funds will be distributed as pilot projects (early stage or proof-of- principle studies) and development projects (comparatively advanced studies with supportive preliminary data) in years 2-4. Peer review will be conducted by an External Review Panel of experts in genomic technology. 3) Implement community outreach activities to encourage awareness of Genome Technology Program successes and facilitate access by the scientific community. We will develop and manage an Education and Outreach Working Group composed of grantees and educational experts to identify and prioritize areas of development for educational materials, and host and advertise a website to distribute those materials. A targeted effort will be made to expose underrepresented and underserved populations in science to the advances and importance of the Genome Technology Program. Informational resources related to technology transfer and intellectual property will be developed for grantees. The Jackson Laboratory (JAX) is uniquely qualified to serve as the GTCC for the Genome Technology Program. The Laboratory has over ninety years of history in supporting mammalian genetics research including through the provision of widely used information resources (e.g. Mouse Genome Informatics) and educational programs including the Annual Short Course on Experimental Models of Human Cancer (29 years), and the McKusick Short Course on Human and Mammalian Genetics and Genomics (nearly 60 years). The Jackson Laboratory for Genomic Medicine was established in 2012 to apply the Lab’s expertise in genomics and technology development toward improvements in genome-based medicine.
项目摘要 NHGRI的基因组技术组合包括大量多样的科学方法, 目标,从仪器开发到高通量技术应用,再到表征 表型性状的基因组基础。这些研究工作对生物学产生了重要的见解, 疾病,但也有很多机会加快创新,发展和早期传播 基因组技术。基因组技术协调中心(GTCC)的目标是最大限度地提高这些 通过联络受助人和NHGRI计划工作人员,管理研究基金和开发 教育资源,以支持和吹捧基因组技术计划的卓越性。我们建议 以下目标,以实现这些目标:1)促进整个基因组技术计划的合作, 促进有助于实现计划目标的标准。我们将主办和支持 基因组技术和CEGS计划。我们还将在受助人中设立工作组, 建立合作关系,并制定基因组技术的指标和标准。我们将会用这些 成立工作组,以确定该领域的差距,为征集机会基金奠定基础。 2)建立和管理机会基金计划,以支持有前途的新产品的初步开发 技术和想法。这些机会基金将作为试点项目(早期阶段或验证阶段)分发, 原则研究)和发展项目(有初步数据支持的比较先进的研究) 在2-4年。同行审查将由基因组技术专家组成的外部审查小组进行。第三章 开展社区外展活动,鼓励人们了解基因组技术计划的成功 并便利科学界获取。我们将开发和管理一个教育和推广 由受赠方和教育专家组成的工作组,以确定发展领域并确定其优先次序 提供教育材料,并主办和宣传一个网站来分发这些材料。有针对性的努力将是 使科学中代表性不足和服务不足的人群了解科学的进步和重要性, 基因组技术计划与技术转让和知识产权有关的信息资源 将为承授人开发物业。杰克逊实验室(JAX)是唯一有资格担任 GTCC基因组技术计划。该实验室有超过90年的历史, 哺乳动物遗传学研究,包括通过提供广泛使用的信息资源(如小鼠 基因组信息学)和教育计划,包括年度短期课程的实验模型, 人类癌症(29年),以及人类和哺乳动物遗传学和基因组学的McKusick短期课程 (近60年)。杰克逊基因组医学实验室成立于2012年, 在基因组学和技术开发方面的专业知识,以改善基于基因组的医学。

项目成果

期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

数据更新时间:{{ journalArticles.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ monograph.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ sciAawards.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ conferencePapers.updateTime }}

{{ item.title }}
  • 作者:
    {{ item.author }}

数据更新时间:{{ patent.updateTime }}

Mark D ADAMS其他文献

Mark D ADAMS的其他文献

{{ item.title }}
{{ item.translation_title }}
  • DOI:
    {{ item.doi }}
  • 发表时间:
    {{ item.publish_year }}
  • 期刊:
  • 影响因子:
    {{ item.factor }}
  • 作者:
    {{ item.authors }}
  • 通讯作者:
    {{ item.author }}

{{ truncateString('Mark D ADAMS', 18)}}的其他基金

Genome Technologies Coordinating Center
基因组技术协调中心
  • 批准号:
    10571905
  • 财政年份:
    2021
  • 资助金额:
    $ 149.81万
  • 项目类别:
Genome Technologies Coordinating Center
基因组技术协调中心
  • 批准号:
    10213304
  • 财政年份:
    2021
  • 资助金额:
    $ 149.81万
  • 项目类别:
Modular Platform for Combinatorial Epigenome Manipulation
用于组合表观基因组操作的模块化平台
  • 批准号:
    10592628
  • 财政年份:
    2018
  • 资助金额:
    $ 149.81万
  • 项目类别:
Impact of Mitochondrial Genome Variation on extreme Prostate Cancer Disparities
线粒体基因组变异对前列腺癌极端差异的影响
  • 批准号:
    8519389
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
A Digital Microfluidic Systems for Gene Synthesis, Sequencing and Recovery
用于基因合成、测序和恢复的数字微流控系统
  • 批准号:
    8532939
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
A Digital Microfluidic Systems for Gene Synthesis, Sequencing and Recovery
用于基因合成、测序和恢复的数字微流控系统
  • 批准号:
    8352845
  • 财政年份:
    2012
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8535790
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8325561
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Genomics
基因组学
  • 批准号:
    8555234
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:
Evolution of multidrug resistance in Acinetobacter baumannii
鲍曼不动杆菌多重耐药性的演变
  • 批准号:
    8726429
  • 财政年份:
    2011
  • 资助金额:
    $ 149.81万
  • 项目类别:

相似海外基金

WELL-CALF: optimising accuracy for commercial adoption
WELL-CALF:优化商业采用的准确性
  • 批准号:
    10093543
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Collaborative R&D
Investigating the Adoption, Actual Usage, and Outcomes of Enterprise Collaboration Systems in Remote Work Settings.
调查远程工作环境中企业协作系统的采用、实际使用和结果。
  • 批准号:
    24K16436
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Unraveling the Dynamics of International Accounting: Exploring the Impact of IFRS Adoption on Firms' Financial Reporting and Business Strategies
揭示国际会计的动态:探索采用 IFRS 对公司财务报告和业务战略的影响
  • 批准号:
    24K16488
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
ERAMET - Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
ERAMET - 快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10107647
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    EU-Funded
Assessing the Coordination of Electric Vehicle Adoption on Urban Energy Transition: A Geospatial Machine Learning Framework
评估电动汽车采用对城市能源转型的协调:地理空间机器学习框架
  • 批准号:
    24K20973
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Grant-in-Aid for Early-Career Scientists
Ecosystem for rapid adoption of modelling and simulation METhods to address regulatory needs in the development of orphan and paediatric medicines
快速采用建模和模拟方法的生态系统,以满足孤儿药和儿科药物开发中的监管需求
  • 批准号:
    10106221
  • 财政年份:
    2024
  • 资助金额:
    $ 149.81万
  • 项目类别:
    EU-Funded
Our focus for this project is accelerating the development and adoption of resource efficient solutions like fashion rental through technological advancement, addressing longer in use and reuse
我们该项目的重点是通过技术进步加快时装租赁等资源高效解决方案的开发和采用,解决更长的使用和重复使用问题
  • 批准号:
    10075502
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Grant for R&D
Engage2innovate – Enhancing security solution design, adoption and impact through effective engagement and social innovation (E2i)
Engage2innovate — 通过有效参与和社会创新增强安全解决方案的设计、采用和影响 (E2i)
  • 批准号:
    10089082
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
    EU-Funded
De-Adoption Beta-Blockers in patients with stable ischemic heart disease without REduced LV ejection fraction, ongoing Ischemia, or Arrhythmias: a randomized Trial with blinded Endpoints (ABbreviate)
在没有左心室射血分数降低、持续性缺血或心律失常的稳定型缺血性心脏病患者中停用β受体阻滞剂:一项盲法终点随机试验(ABbreviate)
  • 批准号:
    481560
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Operating Grants
Collaborative Research: SCIPE: CyberInfrastructure Professionals InnoVating and brOadening the adoption of advanced Technologies (CI PIVOT)
合作研究:SCIPE:网络基础设施专业人员创新和扩大先进技术的采用 (CI PIVOT)
  • 批准号:
    2321091
  • 财政年份:
    2023
  • 资助金额:
    $ 149.81万
  • 项目类别:
    Standard Grant
{{ showInfoDetail.title }}

作者:{{ showInfoDetail.author }}

知道了